Orthomyxoviridae Infections  >>  Inavir (laninamivir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inavir (laninamivir) / Daiichi Sankyo
NCT01793883 / 2013-000582-36: Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza

Completed
2
639
US, Canada, Europe, RoW
40 mg Laninamivir Octanoate, CS-8958, 80 mg Laninamivir Octanoate, Placebo, Lactose
Biota Scientific Management Pty Ltd, Department of Health and Human Services
Influenza
05/14
05/14
FROSTY, NCT02014649: Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza

Terminated
1/2
15
US
20 mg laninamivir octanoate, CS-8958, Placebo, Lactose, 40 mg laninamivir octanoate
Biota Scientific Management Pty Ltd, Department of Health and Human Services
Influenza
04/14
05/14

Download Options